Notice ID: 01972a08453041a8a53ab1c0c5a961ceCombined Synopsis/Solicitation
Amendment #002-Mammalian Bioreactor Control System � Brand Name or Equal
Archived on October 12, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM UTC−04:00
- Posted
- September 26, 2023
- Notice type
- Combined Synopsis/Solicitation
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIAID
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- RFQ-NIAID-23-2177803
- Notice ID
- 01972a08453041a8a53ab1c0c5a961ce
Description
Amendment #002, dated September 26, 2023. See attached amended RFQ, with changes in yellow highlight. All other RFQ provisions remain the same. The due date has been changed to 9:00 am EDT on Wednesday, September 27, 2023. This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-23-2177803 and the solicitation is issued as a Request for Quotes (RFQ). The purpose of the acquisition is to procure a mammalian bioreactor control system for the Vaccine Production Program (VPP)/Vaccine Research Center (VRC). The Vaccine Production Program (VPP) is the development arm of the Vaccine Research Center. The mission of the VRC is to create and develop potentially lifesaving vaccines for HIV, Ebola, Zika, and other known pathogens and get these potentially lifesaving products into the clinic.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
RFQ-NIAID-23-2177803- Combined Synopsis
- 3×Combined SynopsisCurrentSep 20, 2023
Amendment #002-Mammalian Bioreactor Control System � Brand Name or Equal
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
RFQ-NIAID-23-2177803
Archive Date
Oct 12, 2023
Office Address
BETHESDA, MD, 20892